Edition:
India

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

4.50USD
21 Sep 2018
Change (% chg)

$-0.05 (-1.10%)
Prev Close
$4.55
Open
$4.65
Day's High
$4.80
Day's Low
$4.45
Volume
999,339
Avg. Vol
119,755
52-wk High
$18.15
52-wk Low
$4.00

Chart for

About

Melinta Therapeutics, Inc. develops and commercializes novel antibiotics designed to provide therapeutic solutions. The Company’s lead product is Baxdela, an antibiotic approved by the United States food and drug administration (FDA) for use in the treatment of acute bacterial skin and skin structure infections (ABSSSI). The... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $166.71
Shares Outstanding(Mil.): 52.51
Dividend: --
Yield (%): --

Financials

BRIEF-Melinta Therapeutics Prices Public Offering Of 22.0 Mln Shares At $5/Share

* MELINTA THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

24 May 2018

BRIEF-Melinta Therapeutics Announces Proposed Offering Of Common Stock

* MELINTA THERAPEUTICS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

22 May 2018

BRIEF-Melinta Therapeutics Q1 Loss Per Share $0.95

* MELINTA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,958 -53.00
Johnson & Johnson (JNJ.N) $142.88 +0.90
Pfizer Inc. (PFE.N) $44.06 +0.31
Roche Holding Ltd. (ROG.S) CHF235.15 +0.10
Roche Holding Ltd. (RO.S) CHF235.40 -1.20
Abbott Laboratories (ABT.N) $69.05 +0.26
Bayer AG (BAYGn.DE) €76.52 +0.70
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.50 -0.17
AstraZeneca plc (AZN.L) 5,670.00 +98.00

Earnings vs. Estimates